Established in 2007, StressMarq Biosciences is a bioreagents company producing high-quality, cutting-edge tools for scientific research and drug discovery.

StressMarq is the market leader in the development and commercialization of a range of unique fibrillar, oligomeric, and monomeric protein preparations for use in neurodegenerative disease modelling and drug discovery, including proteins such as alpha synuclein, tau, amyloid beta, SOD1 and TTR. StressMarq’s strategic efforts are focused on expanding the breadth and depth of this product line to assist researchers studying Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.

In addition to our focus on fibrillar proteins for neurodegenerative disease research, our diverse portfolio of antibodies, kits, small molecules, and other proteins are utilized across a range of life sciences including neuroscience, cancer research and cell signaling.

StressMarq products are available worldwide through an extensive network of international distributors in over 45 countries.